Get the Stockscreener App
0.00
100.00%
-0.355
Turnstone Biologics Corp stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.
See More
Previous Close:
$0.355
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$8.21M
Revenue:
$81.89M
Net Income/Loss:
$-55.20M
P/E Ratio:
0.00
EPS:
-2.6959
Net Cash Flow:
$-67.40M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$0.6232
Turnstone Biologics Corp Stock (TSBX) Company Profile
Name
Turnstone Biologics Corp
Sector
Industry
Phone
347-897-5988
Address
9310 ATHENA CIRCLE, SUITE 300, LA JOLLA
Compare TSBX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TSBX
Turnstone Biologics Corp
|
0.00 | 8.21M | 81.89M | -55.20M | -67.40M | -2.6959 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Turnstone Biologics Corp Stock (TSBX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-05-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-15-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-14-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-16-23 | Initiated | SVB Securities | Market Perform |
| Aug-15-23 | Initiated | BofA Securities | Buy |
| Aug-15-23 | Initiated | Piper Sandler | Overweight |
View All
Turnstone Biologics Corp Stock (TSBX) Latest News
Turnstone Biologics Corp Stock Analysis and ForecastGlobal Trade Effects & AI-Based Insights for Consistent Profits - earlytimes.in
Can Turnstone Biologics Corp. stock deliver strong Q4 earningsEarnings Growth Report & Expert-Curated Trade Recommendations - Newser
Will Turnstone Biologics Corp. stock recover faster than market2025 EndofYear Setup & Step-by-Step Swing Trade Plans - Newser
Is Turnstone Biologics Corp. stock attractive for ETFs2025 EndofYear Setup & Precise Swing Trade Alerts - Newser
Volume Summary: Is Turnstone Biologics Corp. stock affected by interest rate hikes2025 AllTime Highs & Risk Controlled Stock Pick Alerts - BỘ NỘI VỤ
What margin trends mean for Turnstone Biologics Corp. stockWeekly Loss Report & Fast Momentum Entry Tips - moha.gov.vn
Will Turnstone Biologics Corp. stock benefit from commodity pricesMarket Risk Analysis & Weekly Watchlist of Top Performers - newser.com
What is the fair value of Turnstone Biologics Corp. stock nowMarket Growth Review & Weekly Watchlist for Hot Stocks - newser.com
Top chart patterns to watch in Turnstone Biologics Corp.Weekly Trade Report & Low Risk Investment Opportunities - newser.com
What technical signals suggest for Turnstone Biologics Corp. stockWeekly Stock Summary & Long-Term Growth Stock Strategies - newser.com
Published on: 2025-11-19 11:19:31 - newser.com
Is Turnstone Biologics Corp. stock a bargain at current levelsJuly 2025 Spike Watch & Reliable Price Breakout Alerts - newser.com
Is Turnstone Biologics Corp. stock a buy on dipsQuarterly Portfolio Summary & Technical Confirmation Trade Alerts - newser.com
Sentiment analysis tools applied to Turnstone Biologics Corp.Exit Point & Verified Short-Term Trading Plans - newser.com
Can Turnstone Biologics Corp. stock resist sector downturnsJuly 2025 Trends & AI Driven Price Forecasts - newser.com
Can Turnstone Biologics Corp. stock maintain operating marginsGap Up & Low Drawdown Investment Ideas - Fundação Cultural do Pará
Institutional scanner results for Turnstone Biologics Corp.Risk Management & Verified Short-Term Trading Plans - newser.com
What drives Turnstone Biologics Corp stock priceAutomated Trading Signals & Low Risk Investment Growth - earlytimes.in
XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements - The Manila Times
XOMA Royalty (NASDAQ: XOMA) reports $43.9M YTD cash receipts, completes Turnstone acquisition - Stock Titan
How Turnstone Biologics Corp. stock valuations compare to rivals2025 Price Targets & Long Hold Capital Preservation Tips - newser.com
Why Containerway International Limited Stock Might Outshine Tech Rivals in YEARStock Price Targets & Double Or Triple Profits - earlytimes.in
Why Turnstone Biologics Corp. stock is favored by pension fundsCPI Data & Safe Capital Growth Tips - newser.com
Published on: 2025-11-06 09:52:25 - newser.com
Will Turnstone Biologics Corp. stock maintain momentum in 2025Market Risk Report & Free Reliable Trade Execution Plans - newser.com
Published on: 2025-11-06 02:11:26 - newser.com
Why Turnstone Biologics Corp. stock is trending among retail traders2025 Market Sentiment & Risk Managed Investment Signals - Fundação Cultural do Pará
Turnstone Biologics Corp Stock (TSBX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):